Mortality in non-cystic fibrosis bronchiectasis: A prospective cohort analysis

Respiratory Medicine

Volumn 108, Issue 2, 2014, Pages 287-296

  Goeminne, P C ^a   Nawrot, T S ^b   Ruttens, D ^a   Seys, S ^c   Dupont, L J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b HASSELT UNIVERSITY   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Bronchiectasis; Chronic colonization; COPD; Mortality; Pseudomonas aeruginosa; Survival

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CLARITHROMYCIN; COLISTIMETHATE; ETHAMBUTOL; ISONIAZID; ITRACONAZOLE; MOXIFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; VORICONAZOLE;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; ADULT; AGED; ANEURYSM RUPTURE; ARTICLE; ASPERGILLUS FUMIGATUS; BELGIUM; BRONCHIECTASIS; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYSTIC FIBROSIS; EUTHANASIA; FEMALE; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HEAD INJURY; HEART ARRHYTHMIA; HEART FAILURE; HIGH RESOLUTION COMPUTED TOMOGRAPHY; HUMAN; INTOXICATION; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORAXELLA CATARRHALIS; MORTALITY; NON CYSTIC FIBROSIS BRONCHIECTASIS; PANCREAS TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; SPIROMETRY; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIA; UNIVERSITY HOSPITAL;

BRONCHIECTASIS; CHRONIC COLONIZATION; COPD; MORTALITY; PSEUDOMONAS AERUGINOSA; SURVIVAL;

AGED; BELGIUM; BRONCHIECTASIS; CAUSE OF DEATH; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SMOKING; SOCIOECONOMIC FACTORS;

EID: 84893738209     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.12.015     Document Type: Article

References (41)

1. P. Goeminne, and L. Dupont Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century Postgrad Med J 86 2010 493 501
2. A. De Soyza, J.S. Brown, and M.R. Loebinger Research priorities in bronchiectasis Thorax 68 2013 695 696
3. H.J. Roberts, and R. Hubbard Trends in bronchiectasis mortality in England and Wales Respir Med 104 2010 981 985
4. M. Dupont, A. Gacouin, and H. Lena et al. Survival of patients with bronchiectasis after the first ICU stay for respiratory failure Chest 125 2004 1815 1820
5. J.D. Finklea, G. Khan, S. Thomas, J. Song, D. Myers, and A.C. Arroliga Predictors of mortality in hospitalized patients with acute exacerbation of bronchiectasis Respir Med 104 2010 816 821
6. M.E. Roberts, L. Lowndes, D.G. Milne, and C.A. Wong Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis Intern Med J 42 2012 e129 e136
7. T. Keistinen, O. Saynajakangas, T. Tuuponen, and S.L. Kivela Bronchiectasis: an orphan disease with a poorly-understood prognosis Eur Respir J 10 1997 2784 2787
8. P.C. Goeminne, H. Scheers, A. Decraene, S. Seys, and L.J. Dupont Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients Respir Res 13 2012 21
9. M.R. Loebinger, A.U. Wells, and D.M. Hansell et al. Mortality in bronchiectasis: a long-term study assessing the factors influencing survival Eur Respir J 34 2009 843 849
10. Z.P. Onen, B.E. Gulbay, and E. Sen et al. Analysis of the factors related to mortality in patients with bronchiectasis Respir Med 101 2007 1390 1397
11. A.S. Brody, J.S. Klein, P.L. Molina, J. Quan, J.A. Bean, and R.W. Wilmott High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests J Pediatr 145 2004 32 38
12. T.W. Lee, K.G. Brownlee, S.P. Conway, M. Denton, and J.M. Littlewood Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients J Cyst Fibros 2 2003 29 34
13. N. Galie, M.M. Hoeper, M. Humbert ESC Committee for Practice Guidelines (CPG) Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
14. M.R. Miller, R. Crapo, and J. Hankinson et al. General considerations for lung function testing Eur Respir J 26 2005 153 161
15. M.R. Miller, J. Hankinson, and V. Brusasco et al. Standardisation of spirometry Eur Respir J 26 2005 319 338
16. Federale Overheidsdienst Economie (FOD), Algmene Directie Statistiek en Economische Informatie (ADSEI) http://statbel.fgov.be/nl/statistieken/cijfers/ bevolking/sterfte-leven/sterfte/.
17. I. Barat, F. Andreasen, and E.M. Damsgaard Drug therapy in the elderly: what doctors believe and patients actually do Br J Clin Pharmacol 51 2001 615 622
18. M.C. Wong, R.K. Lau, J.Y. Jiang, and S.M. Griffiths Discontinuation of angiotensin-converting enzyme inhibitors: a cohort study J Clin Pharm Ther 37 2012 335 341
19. M.A. Martinez-Garcia, J.J. Soler-Cataluna, and S.Y. Donat et al. Factors associated with bronchiectasis in patients with COPD Chest 140 2011 1130 1137
20. S.A. Novosad, and A.F. Barker Chronic obstructive pulmonary disease and bronchiectasis Curr Opin Pulm Med 19 2013 133 139
21. A.E. O'Donnell Bronchiectasis in patients with COPD: a distinct COPD phenotype? Chest 140 2011 1107 1108
22. C. O'Brien, P.J. Guest, S.L. Hill, and R.A. Stockley Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care Thorax 55 2000 635 642
23. I.S. Patel, I. Vlahos, and T.M. Wilkinson et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease Am J Respir Crit Care Med 170 2004 400 407
24. M.A. Martinez-Garcia, D. de la Rosa Carrillo, and J.J. Soler-Cataluna et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease Am J Respir Crit Care Med 187 2013 823 831
25. D.R. Swinson, D. Symmons, U. Suresh, M. Jones, and J. Booth Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis Br J Rheumatol 36 1997 689 691
26. P.C. Goeminne, P. Verschueren, H. Scheers, and L.J. Dupont Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: a retrospective and cohort analysis Clin Rheumatol 31 2012 367 373
27. G. Davies, A.U. Wells, S. Doffman, S. Watanabe, and R. Wilson The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis Eur Respir J 28 2006 974 979
28. C.B. Wilson, P.W. Jones, C.J. O'Leary, D.M. Hansell, P.J. Cole, and R. Wilson Effect of sputum bacteriology on the quality of life of patients with bronchiectasis Eur Respir J 10 1997 1754 1760
29. M.A. Martinez-Garcia, J.J. Soler-Cataluna, M. Perpina-Tordera, P. Roman-Sanchez, and J. Soriano Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis Chest 132 2007 1565 1572
30. P.C. Goeminne, J. Vandooren, and E.A. Moelants et al. The sputum colour chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis Respirology 2013 10.1111/resp.12219 [Epub ahead of print]
31. Martínez-García MA, de Gracia J, Vendrell Relat M, et al. Multidimensional approach to non-cystic fibrosis bronchiectasis. The FACED score. Eur Respir J. http://dx.doi.org/10.1183/09031936.00026313 [Epub ahead of print].
32. J.D. Chalmers, P. Goeminne, and S. Aliberti et al. The bronchiectasis severity Index: an international derivation and validation study Am J Respir Crit Care Med 2013 10.1164/rccm.201309-1575OC [Epub ahead of print]
33. A. De Soyza, A. Perry, and A.J. Hall et al. Molecular epidemiological analysis suggests cross infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis Eur Respir J 2013 10.1183/09031936.00167813 [Epub ahead of print]
34. A. Devaraj, A.U. Wells, M.G. Meister, M.R. Loebinger, R. Wilson, and D.M. Hansell Pulmonary hypertension in patients with bronchiectasis: prognostic significance of CT signs AJR Am J Roentgenol 196 2011 1300 1304
35. O.A. Minai, H. Fessler, and J.K. Stoller et al. Clinical characteristics and prediction of pulmonary hypertension in severe emphysema Respir Med 2013 10.1016/j.rmed.2013.11.006 [Epub ahead of print]
36. O.A. Minai, A. Chaouat, and S. Adnot Pulmonary hypertension in COPD: epidemiology, significance, and management Chest 137 2010 39S 51S
37. A.H. Alzeer, A.F. Al-Mobeirek, H.A. Al-Otair, U.A. Elzamzamy, I.A. Joherjy, and A.S. Shaffi Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis Chest 133 2008 468 473
38. G.A. Anwar, S.C. Bourke, G. Afolabi, P. Middleton, C. Ward, and R.M. Rutherford Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis Respir Med 102 2008 1494 1496
39. P.C. Goeminne, J. Soens, H. Scheers, W. De Wever, and L.J. Dupont Effect of macrolide on lung function and computed tomography (CT) score in non-cystic fibrosis bronchiectasis Acta Clin Belg 67 2012 338 346
40. C. Wong, L. Jayaram, and N. Karalus et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial Lancet 380 2012 660 667
41. J. Altenburg, C.S. de Graaff, and Y. Stienstra et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial JAMA 309 2013 1251 1259